[go: up one dir, main page]

SE8305866L - Heterocykliska foreningar och forfaranden for deras framstellning - Google Patents

Heterocykliska foreningar och forfaranden for deras framstellning

Info

Publication number
SE8305866L
SE8305866L SE8305866A SE8305866A SE8305866L SE 8305866 L SE8305866 L SE 8305866L SE 8305866 A SE8305866 A SE 8305866A SE 8305866 A SE8305866 A SE 8305866A SE 8305866 L SE8305866 L SE 8305866L
Authority
SE
Sweden
Prior art keywords
compounds
cycloalkyl
image
treatment
procedures
Prior art date
Application number
SE8305866A
Other languages
English (en)
Other versions
SE8305866D0 (sv
Inventor
A J Crame
A D Borthwick
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8305866D0 publication Critical patent/SE8305866D0/sv
Publication of SE8305866L publication Critical patent/SE8305866L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE8305866A 1982-10-25 1983-10-25 Heterocykliska foreningar och forfaranden for deras framstellning SE8305866L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8230379 1982-10-25

Publications (2)

Publication Number Publication Date
SE8305866D0 SE8305866D0 (sv) 1983-10-25
SE8305866L true SE8305866L (sv) 1984-04-26

Family

ID=10533819

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8305866A SE8305866L (sv) 1982-10-25 1983-10-25 Heterocykliska foreningar och forfaranden for deras framstellning

Country Status (18)

Country Link
US (1) US4496579A (sv)
JP (1) JPS5998086A (sv)
KR (1) KR840006486A (sv)
AU (1) AU2055283A (sv)
BE (1) BE898072A (sv)
CH (1) CH661046A5 (sv)
DE (1) DE3338753A1 (sv)
ES (1) ES8504200A1 (sv)
FI (1) FI833887A (sv)
FR (1) FR2534921B1 (sv)
GB (1) GB2129795B (sv)
GR (1) GR79405B (sv)
IL (1) IL70034A0 (sv)
IT (1) IT1212893B (sv)
LU (1) LU85059A1 (sv)
NL (1) NL8303673A (sv)
SE (1) SE8305866L (sv)
ZA (1) ZA837921B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8410459D0 (en) * 1984-04-24 1984-05-31 Glaxo Group Ltd Chemical compounds
DK160556C (da) * 1984-04-24 1991-09-02 Glaxo Group Ltd Benzodioxinpyrrolderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
GB8526210D0 (en) * 1985-10-23 1985-11-27 Glaxo Group Ltd Chemical compounds
US4769367A (en) * 1984-04-24 1988-09-06 Glaxo Group Limited Heterocyclic amino compounds
GB8526209D0 (en) * 1985-10-23 1985-11-27 Glaxo Group Ltd Chemical process
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
GB8828032D0 (en) * 1988-12-01 1989-01-05 Glaxo Group Ltd Medicaments
DE10107243A1 (de) * 2001-02-16 2002-08-22 Bayer Ag Benzodioxinopyrrole, deren Herstellung und Verwendung
US20070078569A1 (en) * 2005-09-30 2007-04-05 Jeffrey Schox Vehicle interface to communicate a safety alert mode command
US20070074922A1 (en) * 2005-09-30 2007-04-05 Coombs Joshua D Vehicle interface based on a shift of the torso of a user
US20070074921A1 (en) * 2005-09-30 2007-04-05 Coombs Joshua D Vehicle interface based on a shift of the appendages of a user
US20090076686A1 (en) * 2005-09-30 2009-03-19 Jeffrey Schox Vehicle interface to communicate a safety alert mode command
US8099200B2 (en) 2005-09-30 2012-01-17 Coombs Joshua D Vehicle interface based on the weight distribution of a user

Also Published As

Publication number Publication date
NL8303673A (nl) 1984-05-16
GB2129795A (en) 1984-05-23
ES526738A0 (es) 1985-04-16
DE3338753A1 (de) 1984-04-26
KR840006486A (ko) 1984-11-30
BE898072A (fr) 1984-04-25
IL70034A0 (en) 1984-01-31
FI833887A (fi) 1984-04-26
AU2055283A (en) 1984-05-03
FR2534921A1 (fr) 1984-04-27
GB2129795B (en) 1986-02-12
LU85059A1 (fr) 1985-06-19
US4496579A (en) 1985-01-29
SE8305866D0 (sv) 1983-10-25
CH661046A5 (fr) 1987-06-30
IT1212893B (it) 1989-11-30
JPS5998086A (ja) 1984-06-06
FI833887A0 (fi) 1983-10-25
GR79405B (sv) 1984-10-22
ES8504200A1 (es) 1985-04-16
GB8328468D0 (en) 1983-11-23
FR2534921B1 (fr) 1987-01-16
ZA837921B (en) 1985-04-24
IT8349214A0 (it) 1983-10-25

Similar Documents

Publication Publication Date Title
SE8305866L (sv) Heterocykliska foreningar och forfaranden for deras framstellning
DK623586D0 (da) Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne
JPS57171968A (en) 1,4-dihydropyridine derivative
KR950032267A (ko) 11,21-비스페닐-19-노르프레그난 유도체
BG100154A (en) Carbazole derivatibes having inhibiting effect to 17,20-lyase
KR910011816A (ko) 세로토닌 길항질, 그의 제조 및 그를 함유하는 조성물
ES8207150A1 (es) Un procedimiento para la pre-paracion de imidazolilfenilami-dinas.
IE821896L (en) 1-phenyl-2-amino carbonylindole compounds
DK326481A (da) Fremgangsmaade til fremstilling af i 5-stillingen substituerede 5,10-dihydro-11h-dibenzo (b,e) (1,4) diazepin-11-oner eller syreadditionssalte deraf
KR870008842A (ko) N-[2-{[(2- 히드록시 페닐)(페닐)메틸렌]아미노}에틸]아세트아미드 유도체, 그의 제법 및 치료에의 응용
JPS56103168A (en) Thiazole derivative, its preparation, and antihistaminic agent containing the same
HUT42440A (en) Process for preparing novel indole-carboxamide derivatives and pharmaceutical compositions comprising such compounds
IE56209B1 (en) Piperidinedione derivatives,processing anti-arrythmic activity,for protecting the myocardium,process for their preparation and pharmaceutical compositions containing said derivatives
ATE16804T1 (de) Pyrid-3-yl oder piperidin-3-yl-indolon-derivate, ihre salze, verfahren zur herstellung, zusammensetzungen die sie enthalten und die verwendung als heilmittel.
DK156064C (da) Analogifremgangsmaade til fremstilling af 2,4-(1h,3h)-quinazolindionderivater eller farmaceutisk acceptable syreadditionssalte deraf
AU678320B2 (en) N-p-Halobenzoylmethyl derivatives of 4-(p-fluorophenyl)-3-((3,4-(methylene-dioxy)phenoxy)methyl) piperidine
DE3560945D1 (en) Aminoalcohols, process for their preparation and medicaments containing these compounds and intermediates
ATE8786T1 (de) Indolobenzoxazinderivate, ihre salze, verfahren zur herstellung, ihre verwendung als arzneimittel und sie enthaltende zusammensetzungen.
AU564457B2 (en) Phlorophenone derivatives
US5087627A (en) Agent for treatment of disorders of the cerebro-neural transmission system
IL72647A0 (en) Indole derivatives,their preparation and pharmaceutical compositions containing them
EP0001759B1 (en) (omega-aminoalkoxy) bibenzyls, processes for their preparation and pharmaceutical compositions containing these substances
HUT36469A (en) Process for producing 2-/n-pyrrolidino/-3-isobuthyloxy-n-/substituted phenyl/-n-benzyl-propyl-amines and acid additional salts thereof
RU2006105792A (ru) Производные 2,4 (фениламино)пиперидин-1-ил-n-фенилацетамида и родственные соединения в качестве y5 (npy5) лигандов для лечения ожирения
SU1355128A3 (ru) Способ получени пиперазинсодержащих производных алкилтиола или алкилтиокарбамата или их солей

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8305866-9

Effective date: 19851011